105 related articles for article (PubMed ID: 2577091)
1. Prognostic factors including clinical markers.
Glimelius B
Cancer Treat Res; 1989; 41():89-96. PubMed ID: 2577091
[No Abstract] [Full Text] [Related]
2. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
Hsi ED
Leuk Lymphoma; 2008 Sep; 49(9):1668-80. PubMed ID: 18798102
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of biological markers in paediatric Hodgkin lymphoma.
Farruggia P; Puccio G; Sala A; Todesco A; Buffardi S; Garaventa A; Bottigliero G; Bianchi M; Zecca M; Locatelli F; Pession A; Pillon M; Favre C; D'Amico S; Provenzi M; Trizzino A; Zanazzo GA; Sau A; Santoro N; Murgia G; Casini T; Mascarin M; Burnelli R;
Eur J Cancer; 2016 Jan; 52():33-40. PubMed ID: 26630532
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Chan FC; Mottok A; Gerrie AS; Power M; Nijland M; Diepstra A; van den Berg A; Kamper P; d'Amore F; d'Amore AL; Hamilton-Dutoit S; Savage KJ; Shah SP; Connors JM; Gascoyne RD; Scott DW; Steidl C
J Clin Oncol; 2017 Nov; 35(32):3722-3733. PubMed ID: 28898161
[TBL] [Abstract][Full Text] [Related]
5. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of tumor burden at diagnosis in Hodgkin lymphoma.
Gobbi PG; Broglia C; Di Giulio G; Mantelli M; Anselmo P; Merli F; Zinzani PL; Rossi G; Callea V; Iannitto E; Paulli M; Garioni L; Ascari E
Cancer; 2004 Oct; 101(8):1824-34. PubMed ID: 15372482
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Biomarkers for Hodgkin Lymphoma.
Staege MS; Kewitz S; Bernig T; Kühnöl C; Mauz-Körholz C
Pediatr Hematol Oncol; 2015; 32(7):433-54. PubMed ID: 26380871
[TBL] [Abstract][Full Text] [Related]
9. Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome.
Caliò A; Zamò A; Ponzoni M; Zanolin ME; Ferreri AJ; Pedron S; Montagna L; Parolini C; Fraifeld VE; Wolfson M; Yanai H; Pizzolo G; Doglioni C; Vinante F; Chilosi M
Clin Cancer Res; 2015 Nov; 21(22):5164-72. PubMed ID: 26199387
[TBL] [Abstract][Full Text] [Related]
10. Unusual radiologic and histologic manifestations of primary pulmonary lymphoma.
Baccari-Ezzine S; Bouzaidi K; Chelbi E; Ali MB; Ghrairi H
Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):362-4. PubMed ID: 24585921
[TBL] [Abstract][Full Text] [Related]
11. [Predictors and prognostic models in childhood and adolescent Hodgkin's disease].
Kuleva SA; Kolygin BA
Vopr Onkol; 2010; 56(3):272-7. PubMed ID: 20804047
[No Abstract] [Full Text] [Related]
12. Prognostic factors in malignant lymphomas (Hodgkin and non-Hodgkin).
Ascari E; Gobbi PG
Acta Haematol; 1987; 78 Suppl 1():146-50. PubMed ID: 3124438
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of the histologic type of Hodgkin's disease as a prognostic factor].
Shust VF; Markochev AB; Skripkina NS
Vopr Onkol; 1989; 35(10):1251-4. PubMed ID: 2596072
[TBL] [Abstract][Full Text] [Related]
14. [PROGNOSTIC RISK FACTORS FOR NEWLY DIAGNOSED PATIENTS WITH ADVANCED STAGES CLASSICAL HODGKIN'S LYMPHOMA].
Novosad OI; Kriachok IA; Grabovyy OM; Antonuk SA
Lik Sprava; 2014; (9-10):88-94. PubMed ID: 26492782
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers of disease activity in Hodgkin's disease.
Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
[TBL] [Abstract][Full Text] [Related]
16. Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.
Britto L; Spector N; Scheliga A
Cancer; 2007 Jul; 110(1):228-9; author reply 229. PubMed ID: 17487857
[No Abstract] [Full Text] [Related]
17. [Nuclear magnetic resonance in onco-hematology].
Tesoro-Tess JD; Balzarini L; Ceglia E; Petrillo R; Reyner Y; Musumeci R
Haematologica; 1991 Jun; 76 Suppl 3():26-33. PubMed ID: 1752520
[No Abstract] [Full Text] [Related]
18. CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients.
Aldred V; Vassallo J; Froes M Campos AH; Augusto Soares F
Leuk Lymphoma; 2008 Nov; 49(11):2198-202. PubMed ID: 18661400
[No Abstract] [Full Text] [Related]
19. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma.
Jakovic LR; Mihaljevic BS; Perunicic Jovanovic MD; Bogdanovic AD; Andjelic BM; Bumbasirevic VZ
Leuk Lymphoma; 2011 Oct; 52(10):1913-9. PubMed ID: 21663512
[TBL] [Abstract][Full Text] [Related]
20. The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma.
La Nasa G; Greco M; Littera R; Oppi S; Celeghini I; Caria R; Lai S; Porcella R; Martino M; Romano A; Di Raimondo F; Gallamini A; Carcassi C; Caocci G
J Hematol Oncol; 2016 Mar; 9():26. PubMed ID: 26983546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
